These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 33737019)

  • 1. Investigating the heat sensitivity of frequently used excipients with varying particle sizes.
    Grumann HD; Kleinebudde P
    Eur J Pharm Biopharm; 2023 Nov; 192():1-12. PubMed ID: 37716476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the transfer and scale-up of mini-tableting: Case study with losartan potassium.
    Lura V; Klinken S; Breitkreutz J
    Eur J Pharm Biopharm; 2023 Nov; 192():161-173. PubMed ID: 37820883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator.
    Chen B; Zhang F; Dhupia J; Morgenstern MP; Costello M; Boyce H; Sun WJ; Raofi S; Tian L; Xu W
    AAPS PharmSciTech; 2023 Nov; 24(8):245. PubMed ID: 38030835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Microcrystalline Cellulose-CaHPO
    Mohylyuk V; Paulausks A; Radzins O; Lauberte L
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro test methods for evaluating high molecular weight polyethylene oxide polymer induced hemolytic and thrombotic potential.
    Kim D; Natu R; Malinauskas R; Baek JH; Buehler PW; Feng X; Qu H; Pinto J; Xu X; Herbertson L
    Toxicol In Vitro; 2024 May; 97():105793. PubMed ID: 38401745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cylindrical granules in the development of mesalazine solid formulations (Ⅱ): The contribution of high aspect ratio to favorable tabletability.
    Li Z; Wang H; Hou J; Li M; Shi X; Liu B; Chen Z; Liu Q; Fu Q
    Int J Pharm; 2024 Jan; 649():123665. PubMed ID: 38048889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dwell Time on Tableting: Dwell Time According to Force versus Geometric Dwell Time.
    Mohylyuk V
    Pharm Dev Technol; 2024 Jul; ():1-19. PubMed ID: 39046222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy to optimize precompression pressure for tablet manufacturing based on in-die elastic recovery.
    Vreeman G; Calvin Sun C
    Int J Pharm; 2024 Apr; 654():123981. PubMed ID: 38460772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the tensile strength of tablets using LSTM networks on compression profiles.
    De Bisshop J; Klinken S
    Int J Pharm; 2023 Oct; 645():123280. PubMed ID: 37517565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Wet Granulation Parameters on the Compaction Behavior and Tablet Strength of a Hydralazine Powder Mixture.
    Macho O; Gabrišová Ľ; Guštafík A; Jezso K; Juriga M; Kabát J; Blaško J
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets.
    Yu D; Fiddler F; Ibrahim A; Sanedrin R; Tremblay H; Hoag SW
    AAPS PharmSciTech; 2022 Oct; 23(8):282. PubMed ID: 36253562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo Tablets.
    Boyce HJ; Dave VS; Scoggins M; Gurvich VJ; Smith DT; Byrn SR; Hoag SW
    AAPS PharmSciTech; 2020 Jan; 21(3):86. PubMed ID: 31997096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tabletability and compactibility of
    Persson AS; Alderborn G
    Pharm Dev Technol; 2023 Jul; 28(6):509-519. PubMed ID: 37310086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?
    Salwan AJ; Hagemeier NE; Harirforoosh S
    Clin Drug Investig; 2018 Jul; 38(7):573-577. PubMed ID: 29651781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse-deterrent opioids: an update on current approaches and considerations.
    Pergolizzi JV; Raffa RB; Taylor R; Vacalis S
    Curr Med Res Opin; 2018 Apr; 34(4):711-723. PubMed ID: 29262730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tableting performance of Poly (ethylene oxide) in abuse-deterrent formulations using compaction simulation studies.
    Yu D; Seelam RR; Zhang F; Byrn SR; Hoag SW
    J Pharm Sci; 2021 Jul; 110(7):2789-2799. PubMed ID: 33737019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of compressibility and compactibility of poly(ethylene oxide) polymers for modified release application by compaction simulator.
    Yang L; Venkatesh G; Fassihi R
    J Pharm Sci; 1996 Oct; 85(10):1085-90. PubMed ID: 8897276
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.